|Articles|March 1, 2004
- Pharmaceutical Executive-03-01-2004
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 22 years ago
DTC: European Styleover 22 years ago
The Ins and Outs of EAPsover 22 years ago
Is Everyone a Target?over 22 years ago
The Push for Modern ManufacturingAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5